Oramed reaches 50% enrolment in Phase III trial of insulin capsule
The ORA-D-013-2 trial is enrolling 450 type 2 diabetes patients with insufficient glycemic control.
Israel
Latest in
Israel
Enlivex to initiate Phase I/II peritoneal metastases cell therapy trial
The clinical trial of Allocetra will commence with two cohorts of intra-patient and intra-cohort dose escalation.
Biond doses first subjects in Phase I solid tumour therapy trial
The trial will analyse the safety, tolerability, PK, anti-tumour activity and exploratory biomarkers for BND-22 activity.
Clinical trial data company Beaconcure eyes US expansion
Beaconcure’s platform Verify is designed to review clinical trial datasets and pinpoint inconsistencies.
By
NeuroSense previews Phase IIb trial plans for oral ALS drug
NeuroSense CEO Alon Ben-Noon reveals the target patient population and outcome measures of a planned Phase IIb ALS trial to…
By
Oramed ends subject enrolment in Phase II trial of oral insulin for NASH
The company anticipates reporting topline data from the trial in the second half of this year.
Can-Fite enrols first subject in Phase IIb NASH trial
The trial will recruit 140 patients with biopsy-confirmed NASH.
J&J’s Covid-19 booster shot offers greater antibody responses
J&J’s booster given after Pfizer-BioNTech’s two-dose regimen led to a continued rise of antibodies for a minimum of four weeks.